Claude Preudhomme Selected Research

Claude Preudhomme Research Topics

Disease

55	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 11/2005
16	Leukemia 01/2022 - 06/2007
13	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 04/2008
11	Residual Neoplasm 01/2021 - 11/2012
11	Neoplasms (Cancer) 01/2021 - 12/2004
11	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 08/2002
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 08/2002
4	Thrombocytopenia (Thrombopenia) 01/2019 - 02/2011
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2019 - 03/2005
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 12/2017 - 08/2017
3	Anemia 12/2017 - 07/2013
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2021 - 03/2014
2	Philadelphia Chromosome 01/2020 - 02/2006
2	Lymphoma (Lymphomas) 12/2019 - 05/2013
2	GATA2 Deficiency 01/2019 - 01/2019
2	Pdgfra-Associated Chronic Eosinophilic Leukemia 09/2013 - 06/2007
1	VEXAS syndrome 01/2022
1	Clinical Deterioration 07/2020
1	COVID-19 07/2020
1	Acute Promyelocytic Leukemia 01/2018
1	Pathologic Complete Response 01/2018
1	Hemorrhage 01/2018
1	Myeloid Sarcoma (Chloroma) 01/2018
1	Multiple Myeloma 12/2017
1	Cytopenia 12/2017
1	Iron Overload 12/2017
1	Monoclonal Gammopathy of Undetermined Significance 10/2017
1	Hematologic Diseases (Blood Diseases) 12/2016
1	Fatigue 04/2016
1	Disease Progression 03/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2015

Drug/Important Bio-Agent (IBA)

15	Imatinib Mesylate (Gleevec)FDA Link 12/2013 - 08/2002
8	Gemtuzumab (Mylotarg)FDA Link 08/2020 - 04/2012
8	Core Binding Factors (Core-Binding Factor)IBA 12/2018 - 03/2009
7	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 04/2012
7	Transcription Factors (Transcription Factor)IBA 01/2021 - 04/2008
6	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2017 - 03/2009
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
5	Tyrosine Kinase InhibitorsIBA 01/2020 - 08/2002
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2019 - 08/2002
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 04/2008
3	Phosphotransferases (Kinase)IBA 01/2021 - 04/2003
3	Dasatinib (BMS 354825)FDA Link 06/2015 - 12/2008
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2022
2	EnzymesIBA 01/2022 - 08/2010
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 08/2010
2	Biological ProductsIBA 07/2020 - 12/2016
2	Clofarabine (Clolar)FDA Link 12/2019 - 04/2017
2	NucleophosminIBA 10/2019 - 11/2005
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2018 - 06/2015
2	Decitabine FDA Link 02/2016 - 10/2011
2	Interleukin-2 (IL2)IBA 01/2016 - 02/2010
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2013 - 02/2010
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2013 - 02/2010
2	CCAAT-Enhancer-Binding Protein-alphaIBA 12/2010 - 05/2009
1	SOXC Transcription FactorsIBA 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2020
1	Amino Acids FDA Link 12/2020
1	Biological FactorsIBA 07/2020
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2020
1	Antimitotic AgentsIBA 01/2020
1	Vitamin D FDA LinkGeneric 01/2020
1	Asparaginase (Elspar)FDA Link 12/2019
1	Methotrexate (Mexate)FDA LinkGeneric 12/2019
1	Vincristine (Oncovin)FDA LinkGeneric 12/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019
1	Prednisone (Sone)FDA LinkGeneric 12/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 09/2019
1	guadecitabineIBA 01/2019
1	Polycomb Repressive Complex 2IBA 01/2018
1	ChromatinIBA 01/2018
1	CohesinsIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Immunomodulating AgentsIBA 12/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2017
1	IronIBA 12/2017
1	Deferasirox FDA Link 12/2017
1	Immunoglobulin M (IgM)IBA 10/2017
1	CholesterolIBA 12/2016
1	OTX015IBA 04/2016
1	BilirubinIBA 04/2016
1	CytidineIBA 02/2016
1	Lenalidomide (CC 5013)FDA Link 02/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	TetraspaninsIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 12/2015
1	Rituximab (Mabthera)FDA Link 07/2015

Therapy/Procedure

20	Therapeutics 01/2022 - 01/2005
19	Drug Therapy (Chemotherapy) 01/2022 - 06/2005
4	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2017
3	Stem Cell Transplantation 01/2021 - 06/2012
2	Induction Chemotherapy 02/2010 - 06/2007
1	Ligation 10/2021
1	Critical Care (Surgical Intensive Care) 07/2020
1	Immunotherapy 01/2019
1	Transplantation 01/2018
1	Erythrocyte Transfusion 12/2017
1	Salvage Therapy 01/2017